More Seroquel suits dropped on Delaware ruling

Two more cases have been dismissed in Delaware in the sprawling litigation over AstraZeneca's antipsychotic drug Seroquel, as plaintiffs' attorneys voluntarily dismissed cases that had been set for trial in November. Report

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.